Hypertension in women;Hipertensión arterial sistémica en la mujer

Archivos de Cardiologia de Mexico

Volumn 78, Issue SUPPL. 2, 2008, Pages

  Lomeli, Catalina ^a   Rosas Peralta, Martín ^a   Mendoza González, Celso ^a   Lorenzo, José Antonio ^a   Pastelín, Gustavo ^a   Méndez, Arturo ^a   Ferez, Sergio Mario ^a   Attie, Fause ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Cardiovascular disease; Guidelines; Hypertension in women

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; CONJUGATED ESTROGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LISINOPRIL; LOSARTAN; LOW DENSITY LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; PLACEBO; THIAZIDE DIURETIC AGENT;

ADIPOSE TISSUE; ADULT; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL PRACTICE; DIABETES MELLITUS; DYSLIPIDEMIA; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; LIFESTYLE; LIFESTYLE MODIFICATION; LIPID METABOLISM; MENOPAUSAL SYNDROME; MENOPAUSE; MEXICO; MONOTHERAPY; OBESITY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 49749108613     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. THOM T, HAASE N, ROSAMOND W, HOWARD VJ, RUMSFELD I, MANOLIO T, ZHENG ZJ, FLEGAL K, O'DONNELL C, ET AL; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113: e85-e151.
2. LLOYD-JONES DM, EVANS JC, LEVY D: Hypertension in adults across the age spectrum. JAMA 2005; 294(4): 466-472.
3. VELÁZQUEZ-MONROY O, ROSAS PM, LARA EA, PASTELÍN HG. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: Resultados fi nales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Méx 2003; 73: 62-77.
4. WILLIAM BK, HJORTLAND MC, MCNAMARA PM, GORDON T: Menopause and risk of cardiovascular disease. Annals of Internal Medicine 1976; 85: 447-452.
5. CHAPMAN AB, ZAMUDIO S, WOODMANSEE W: Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol 1997; 273: 777-782.
6. DUNNE FP, BARRY DG, FREÍS JB, GREALY G, MURPHY D: Changes in blood pressure during the normal menstrual cycle. Clin Sci Oct 1991; 81: 515-518.
7. KARPANOU EA, VYSSOULIS GP, GEORGOUDI DG, TOUTOUZA MG, TOUTOUZAS PK: Ambulatory blood pressure changes in the menstrual cycle of hypertensive women. Significance of plasma renin activity values. Am J Hypertens 1993; 6: 654-659.
8. AUGUST P, LENZ T, ALES KL, ET AL: Longitudinal study of the renin angiotensin system in hypertensive women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol 1990; 163: 1612-1621.
9. MENDELSOHN ME, KARAS RH: The protective effects of estrogen on the cardiovascular system. The New England Journal of Medicine 1999; 340: 1801-1807.
10. CNOP M, LANDCHILD MJ, VIDAL J: The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistence and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002; 51: 1005-1015.
11. REXRODE KM, CAREY VJ, HENNEKENS CH, WALTERS EE, COLDITZ GA: Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280: 1843-1848.
12. TCHERNOF A, DESMEULES A, RICHARD C, LABERGE P, DARIS M, MAILLOUX J: Ovarian hormon status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab 2004; 89: 3425-3430.
13. NORDBY G, OSI, KJELDSEN SE, EIDE I: Mild essential hypertension in nonobese premenopausal women is characterized by low renin. Am J. Hypertens 1992; 5: 579-584.
14. DUBEY RK, OPARIL S, IMTHURN B, JACKSON EK: Sex hormones and hypertension. Cardiovasc Res 2002; 53: 688-708.
15. RECKELHOFF JF: Gender differences in the regulation of blood pressure. Hypertension 2001; 37: 1199-208.
16. NORDBY G, KJELDSEN SE, EIDE I: Mild essential hypertension in nonobese premenopausal women is characterized by low renin. Am J Hypertens 1992; 5: 579-84.
17. BURT VL, WHELTON P, ROCCELLA EJ, BROWN C, CUTLER JA, HIGGINS M, ET AL: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
18. SOS TA, PICKERING TG, SNIDERMAN K: Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309: 274.
19. WASSRTHEIL-SMOLLER S, ANDERSON G, PSATY BM, ET AL: Hypertension and its treatment in post-menopausal women: basaline data from the Women's Health Initiative. Hypertension 2000; 36: 780-789.
20. STAESSEN JA, GINOCCHIO G, THUS L: Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997; 11: 507-514.
21. MOSCA L, COLLINS P, HERRINGTON DM, ET AL: Hormone replacement therapy and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 499-503.
22. DAHLÖF B, DEVEREUX RB, KJELDSEN SE: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995-1003.
23. THE ALLHAT OFFICERS AND COORDINATORS FOR THE ALLHAT COLLABORATIVE RESEARCH GROUP. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzime inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart A Hack Trial (ALLHA T). JAMA 2002; 288: 2981-2997.